Participants
The sample was selected among the residents of a specialized dementia elderly center in A Coruña (Spain). The inclusion criteria were a diagnosis of dementia and the presence of severe or very severe cognitive decline (GDS, 6-7)
19. Dementia diagnoses was noted on the medical history and provided by a neurologist before placement in the gerontological complex, being corroborated by the elderly center’s medical doctor. GDS was applied by a clinical psychologist with experience in assessing people to determine level of severity: severe (GDS 6) or very severe (GDS 7) cognitive decline. The exclusion criteria were the presence of a sensory disorder that would adversely affect interactions with the multisensory stimulation objects (eg, severe vision and hearing impairment) and be bedridden.
After the clinical psychologist checked the eligibility of participants according to the inclusion and exclusion criteria, the sample consisted of 32 participants. A computer-based random number generator was used to randomly divide the sample into 3 groups of 11, 11, and 10 individuals according to GDS. The initial sample size decreased to 27 during the follow-up period due to participant deaths (n = 4) and dropouts (n = 1). The patients’ progress through the trial is shown in a Consolidated Standards of Reporting Trial (CONSORT) diagram (
Figure 1).
The study protocol was approved by the Ethics Committee at the University of A Coruña followed the principles of the Declaration of Helsinki. Before beginning data collection, all participants’ proxies were informed about the study. Proxies were used as legally authorized representatives to provide informed consent for the elderly individuals having dementia to participate in the research.
Procedure
People from the MSSE group participated in multisensory sessions in a Snoezelen room. This room, that stimulate all the senses except taste, included several elements such as alternating colors fiber-optic cables, 2 water bubble columns within 2 mirrors, a water bed, a rotating mirror ball with a color light projector, a video, an interactive projecting system, musical selections, aroma therapy equipment with fragrant oils, and a tactile board with various textures, among others.
The activity group participated in a series of one-to-one activity sessions, in which intellectual and/or physical demands were placed on the individual, and the approach used is directive, being the therapist the person responsible to choose the activities to be performed. Participants were asked to take part in simple activities such as looking at photographs or playing games. This group was included in the study to differentiate the specific benefits of the multisensory stimulation from those derived from attending one-to-one therapy sessions.
13The control group did not participate in any of the aforementioned activities; rather, this group continued with the daily routines of the center, including cognitive stimulation group sessions (GDS 6), training on activities of daily living (GDS 6), education and training of nursing assistants in dementia knowledge, acknowledgment of resident’s experiences, and communication techniques and behavior management (GDS 6-7).
The design of the sessions followed by the MSSE and the activity groups was based on the protocol suggested by Baker et al.
20 Participants from both groups were required to take part in 2 weekly sessions, for a period of 16 weeks, until they complete 32 sessions. These sessions lasted 30 minutes, unless the participant expressed a desire to leave.
The difference between MSSE and activity sessions was given by the characteristics that define the MSSE. In the MSSE group, multisensory unpatterned stimuli were used, the therapist followed a nondirective approach, and the therapy required few intellectual or physical demands. In contrast, during the activity sessions, no intentional special multisensory experiences were introduced, the therapist followed a directive approach, and intellectual and/or physical demands were placed on the patient.
Data on participants’ sensorial preferences and interests were previously collected to design the content of the sessions and to minimize the behavioral problems that some participants could present within the MSSE and the activity contexts. In the MSSE group, sensorial preferences in the Snoezelen room were assessed based on the procedure suggested by Pace et al.
21 Furthermore, relatives of participants of both groups were interviewed to identify participants’ hobbies and interests.
Behavior, mood, cognition, and dementia severity were assessed at baseline (pretrial, week 0), in the middle (midtrial, week 8), at the end of the intervention (posttrial, week 16), and 8 weeks after the intervention (follow-up). Due to ethical reasons, the control group did not remain without intervention for more than 16 weeks; therefore, this group did not participate in the 8-week follow-up.
Assessment Instruments
The validated Spanish version
22 of the Cohen-Mansfield Agitation Inventory (CMAI)
23 was used to assess the frequency of agitated behaviors in the participants. The CMAI consists of 30 items that are each rated on a 7-point scale of frequency, 1 meaning never and 7 several times per hour. The total score is calculated by summing the scores of each of the individual items. Through a factor analysis, Cohen-Mansfield et al
23 found the following 3 factors of agitation in the nursing home: “aggressive behavior” (hitting, kicking, pushing, scratching, tearing things, cursing or verbal aggression, and grabbing); “physically nonaggressive behavior” (pacing, inappropriate robing or disrobing, trying to get to a different place, handling things inappropriately, general restlessness, and repetitious mannerisms); and “verbally agitated behavior” (complaining, constant requests for attention, negativism, repetitious sentences or questions, and screaming). In this study, for each factor the total score was obtained by summing the scores of the corresponding items. The CMAI interrater reliability
23 ranges from .88 to .92 and the internal consistency reliabilities (Cronbach’s α)
24 range from .86 to .91.
Behavior was assessed using the Spanish version
25 of the Neuropsychiatric Inventory (NPI).
26 This scale was developed to assess a wide range of behaviors in patients with Alzheimer’s disease and other dementias. The NPI questionnaire evaluates 12 neuropsychiatric disturbances including delusions, hallucinations, agitation, dysphoria/depression, anxiety, euphoria, apathy, disinhibition, irritability, aberrant motor behavior, sleep and night-time behavior disturbances, and changes in appetite and eating behaviors. Neuropsychiatric Inventory is completed according to the answers of the caregivers. A group of screening questions are asked first, which are followed by a series of subsequent questions if the response to the initial screening indicates the presence of neuropsychiatric alterations. The caregiver rates the frequency of the symptoms using scores from 1 to 4 (1 = occasionally, less than once per week; 4 = very frequently, once or more per day or continuously) and also rates the severity using scores from 1 to 3 (1 = mild, 2 = moderate, and 3 = severe). The total score ranges from 0 to 144, with higher values indicating more behavioral and psychological alterations. The Spanish version of the NPI
25 has shown good internal consistence (α = .85) and interrater reliability (.63 to 1.00).
The Spanish version
27 of the Cornell Scale for Depression in Dementia (CSDD)
28 was used to assess mood. This scale was specifically developed to assess signs and symptoms of major depression in patients with dementia. Information is elicited through 2 semistructured interviews: an interview with an informant and an interview with the patient. The CSDD consists of 19 items that are rated for severity on a scale of 0 to 2 (0 =
absent, 1 =
mild or intermittent, 2 =
severe). Total score is obtained by summing the scores for all items, being the minimum score 0 and the maximum score 38. Scores above 10 indicate probable major depression. Scores above 18 indicate definite major depression. In the Spanish population, CSDD has shown good test–retest reliability (.61 to .84) and good internal consistency (α = .81).
27To assess cognitive function, the Spanish version
29 of the Severe Mini-Mental State Examination (SMMSE)
30 was used. The SMMSE was designed for assessment of severe dementia preventing the floor effect found when using the MMSE.
31 This simple instrument does not require specialized training or foreign material, and it is not tiring for the patient with dementia (takes less than 5 minutes to administer). It consists of 10 items related with autobiographical knowledge (complete name and birth date), constructional praxis tests, phonological loop (spelling), and semantic verbal fluency step (animal category generation). The SMMSE also tests receptive and expressive language skills, along with elementary executive functions and visual–spatial abilities, which are likely to be preserved in patients with severe impairment. The total score ranges from 0 to 30 points, with lower values indicating lower cognitive function. The SMMSE has shown both construct and criterion validity for assessing patients with severely impaired Alzheimer’s disease.
30 In the Spanish population, SMMSE has shown high internal consistency (α = .88), test–retest reliability (.64 to 1.00), interrater reliability (.69 to 1.00), and construct validity in correlation with the Spanish version of the Mini-Mental State Examination (Pearson
r coefficient = .59).
29The overall severity of dementia was measured by the Bedford Alzheimer Nursing Severity Scale (BANS-S).
32 The BANS-S is an observational scale that can be used even with persons who are unable to follow simple commands, uncooperative, or unable to communicate. This is a 7-item scale that combines ratings of interaction ability (speech, eye contact), functional deficits (dressing, eating, and ambulation), and occurrence of pathological symptoms (sleep–wake cycle disturbance, muscle rigidity).
33 Each item is scored on a 4-point scale where a scoring system is specified for each item. The total score ranges from 7 (no impairment) to 28 (most severe impairment). The BANS-S is more sensitive to detecting disease progression beyond the severe stage than scales that measure only cognitive or functional deficits.
32 BANS-S has shown good internal consistence (α = .80), convergent validity with other cognitive and functional scales (
r = .62-.79), and discriminant validity in comparison with the NPI (
r = .36).
32,34Statistical Analysis
Sample characteristics were summarized as mean and standard deviation (SD) for the continuous variables and as frequency and percentage for the categorical variables. The Shapiro-Wilk test was used to evaluate the normality of the sample. This test is more appropriate for small sample sizes (< 50 samples).
35 Differences between groups at baseline were compared using chi-square test for proportions and the nonparametric Mann Whitney U test for nonnormally distributed continuous variables. Statistical significance was set at a
P value of less than .05.
Finally, repeated measures two-way analysis of variance (two-way mixed ANOVAs) (two-way mixed ANOVAs) was used to assess performance differences in behavior, mood, and cognitive status and dementia severity over the pre-, mid-, and posttrial assessment points. In the first analysis, the within-subject variable was the measures over time (pre-, mid-, and posttrial assessment) and the between-subject variable included the group (MSSE and activity). In the second analysis, the within-subject variable was the measures overtime (pre-, mid-, and posttrial assessment) and the between-subject variable included the group (MSSE and control).
In addition, repeated measures two-way mixed ANOVAs were used to assess performance differences in behavior, mood, and cognition, and dementia severity between the posttrial and the 8-week follow-up. In this case, the within-subject variable was the measures over time (posttrial assessment and follow-up) and the between-subject variable included the group (MSSE and activity).
Differences between groups were tested by a group–time interaction. Eta-squared values (η
2) were reported as indicators of effect size. We interpreted the importance of the effect size using the benchmarks for “small” (η
2 of .02), “medium” (η
2 of .13) and “large” (η
2 of .26) offered by Cohen (1988).
36 Statistical significance was set at a P value of less than .05. Statistical analysis was performed using the SPSS version 20.